These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24392141)

  • 1. Albinism-causing mutations in recombinant human tyrosinase alter intrinsic enzymatic activity.
    Dolinska MB; Kovaleva E; Backlund P; Wingfield PT; Brooks BP; Sergeev YV
    PLoS One; 2014; 9(1):e84494. PubMed ID: 24392141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
    Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.
    Wachamo SA; Patel MH; Varghese PK; Dolinska MB; Sergeev YV
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein.
    Kus NJ; Dolinska MB; Young KL; Dimitriadis EK; Wingfield PT; Sergeev YV
    PLoS One; 2018; 13(6):e0198247. PubMed ID: 29870551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector.
    Dolinska MB; Wingfield PT; Sergeev YV
    Curr Protoc Protein Sci; 2017 Aug; 89():6.15.1-6.15.12. PubMed ID: 28762492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase.
    Dolinska MB; Sergeev YV
    Biol Chem; 2017 Dec; 399(1):73-77. PubMed ID: 28858842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants.
    Dolinska MB; Anderson DE; Sergeev YV
    Protein Sci; 2023 Jan; 32(1):e4518. PubMed ID: 36412553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
    Toyofuku K; Wada I; Spritz RA; Hearing VJ
    Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits.
    Song Y; Zhang Y; Chen M; Deng J; Sui T; Lai L; Li Z
    EBioMedicine; 2018 Oct; 36():517-525. PubMed ID: 30274819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure and function of the mouse tyrosinase locus.
    Seruggia D; Josa S; Fernández A; Montoliu L
    Pigment Cell Melanoma Res; 2021 Mar; 34(2):212-221. PubMed ID: 33098271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tyrosinase missense mutation causes albinism in the Wistar rat.
    Blaszczyk WM; Arning L; Hoffmann KP; Epplen JT
    Pigment Cell Res; 2005 Apr; 18(2):144-5. PubMed ID: 15760344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TYRP1-mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains.
    Dolinska MB; Wingfield PT; Young KL; Sergeev YV
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):753-765. PubMed ID: 31077632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis of histidine mutations on the structural stability of human tyrosinases leading to albinism insurgence.
    Hassan M; Abbas Q; Raza H; Moustafa AA; Seo SY
    Mol Biosyst; 2017 Jul; 13(8):1534-1544. PubMed ID: 28640309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosinase gene in gorillas and the albinism of 'Snowflake'.
    Martínez-Arias R; Comas D; Andrés A; Abelló MT; Domingo-Roura X; Bertranpetit J
    Pigment Cell Res; 2000 Dec; 13(6):467-70. PubMed ID: 11153699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic analysis of human tyrosinase intra-melanosomal domain and mutant variants to further understand oculocutaneous albinism type 1.
    Farney SK; Dolinska MB; Sergeev YV
    J Anal Pharm Res; 2018; 7(6):621-632. PubMed ID: 30868138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Recombinant Expression and Purification of Human Tyrosinase Suitable for Structural Studies.
    Lai X; Soler-Lopez M; Wichers HJ; Dijkstra BW
    PLoS One; 2016; 11(8):e0161697. PubMed ID: 27551823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
    Ray K; Chaki M; Sengupta M
    Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinase Nanoparticles: Understanding the Melanogenesis Pathway by Isolating the Products of Tyrosinase Enzymatic Reaction.
    Varghese PK; Abu-Asab M; Dimitriadis EK; Dolinska MB; Morcos GP; Sergeev YV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
    Oetting WS; King RA
    Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
    Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.